Research library / Metformin

BB Good human data, but mixed outcomes or surrogate markers. How we grade →Secondary analysis of RCT · DPP/DPPOS, about 1,700 people with B12 samples

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

V Aroda, S Edelstein, R Goldberg, W Knowler, S Marcovina, T Orchard et al. The Journal of Clinical Endocrinology & Metabolism. 2016.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
Low vitamin B12 was more common on metformin at 5 years (4.3% vs 2.3%); long-term use was linked to B12 deficiency and anemia.
Limits
Not significant at 13 years for low B12 alone; open-label metformin after year 3.
Which of our grades it feeds
Source
doi.org/10.1210/jc.2015-3754 · PubMed 26900641 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.